Nuveen Asset Management’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-59,701
| Closed | -$363K | – | 3370 |
|
|
2022
Q1 | $363K | Sell |
59,701
-15,940
| -21% | -$96.9K | ﹤0.01% | 3084 |
|
|
2021
Q4 | $954K | Sell |
75,641
-5,236
| -6% | -$66K | ﹤0.01% | 2876 |
|
|
2021
Q3 | $7.41M | Sell |
80,877
-16,475
| -17% | -$1.51M | ﹤0.01% | 1991 |
|
|
2021
Q2 | $5.16M | Buy |
97,352
+27,092
| +39% | +$1.44M | ﹤0.01% | 2230 |
|
|
2021
Q1 | $2.53M | Sell |
70,260
-4,975
| -7% | -$179K | ﹤0.01% | 2500 |
|
|
2020
Q4 | $2.09M | Buy |
75,235
+5,323
| +8% | +$148K | ﹤0.01% | 2488 |
|
|
2020
Q3 | $3.5M | Sell |
69,912
-4,462
| -6% | -$223K | ﹤0.01% | 2108 |
|
|
2020
Q2 | $3.44M | Buy |
74,374
+28,985
| +64% | +$1.34M | ﹤0.01% | 2093 |
|
|
2020
Q1 | $2.07M | Buy |
45,389
+789
| +2% | +$36K | ﹤0.01% | 2167 |
|
|
2019
Q4 | $2.5M | Buy |
44,600
+13,972
| +46% | +$784K | ﹤0.01% | 2330 |
|
|
2019
Q3 | $764K | Buy |
30,628
+15,250
| +99% | +$380K | ﹤0.01% | 2802 |
|
|
2019
Q2 | $654K | Buy |
+15,378
| New | +$654K | ﹤0.01% | 2908 |
|